Elmar Bucher
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
74
Citations
2,495
Est. group size
—
Recurring co-author estimate
Active years
20
Publishing since 2007
Elmar Bucher studies cancer biology with a focus on breast cancer (including aggressive triple-negative forms) and pancreatic cancer. The work combines advanced imaging that maps many molecular markers at once, single-cell and spatial analysis of tumor tissue, and studies of altered cell metabolism to understand tumor heterogeneity, immune responses, and drug resistance. A recurring goal is identifying biomarkers that predict patient outcomes and guide treatment.
Publication activity has grown over the decade, rising sharply around 2022-2023 before recent years, averaging roughly nine publications per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer
Nature Cancer · 2025
- Highly multiplexed imaging reveals prognostic immune and stromal spatial biomarkers in breast cancer
JCI Insight · 2025
- Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancer
Cell Reports · 2025
- Corrigendum to Mutant p53–associated myosin-X upregulation promotes breast cancer invasion and metastasis
Journal of Clinical Investigation · 2025
- NA
immuneACCESS · 2024
- MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer
Nature Communications · 2023
- Robust biomarker discovery through multiplatform multiplex image analysis of breast cancer clinical cohorts
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Supplementary Table 3 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
- Supplementary Table 1 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
- Supplementary Table 2 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
- Supplementary Table 4 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
- Supplementary Table 5 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
- Supplementary Methods from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
- Supplementary Figures 1-2 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
- Supplementary Table 6 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
- bioRxiv (Cold Spring Harbor Laboratory)×9
- Cancer Research×4
- Cell Systems×3
- Communications Biology×2
- JCI Insight×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile